Effects of Naltrexone Sustained- Release
โ
Hollander, P.; Gupta, A. K.; Plodkowski, R.; Greenway, F.; Bays, H.; Burns, C.;
๐
Article
๐
2013
๐
American Diabetes Association
๐
English
โ 682 KB
## OBJECTIVE To assess the efficacy and safety of 32 mg naltrexone sustained-release (SR)/360 mg bupropion SR (NB) in overweight/obese individuals with type 2 diabetes with or without background oral antidiabetes drugs. ## RESEARCH DESIGN AND METHODS This was a 56-week, double-blind, placebo-cont